IR Overview

Corporate Profile

Euda Health Holdings Ltd. aims to become a market leader in non-invasive and preventive healthcare, with a strategic focus on the fast-growing longevity sector. Our mission is to address the evolving healthcare needs of over 1.8 billion people across Southeast Asia and China—regions experiencing significant demographic shifts, where more than 30% of the population is aging rapidly. By offering innovative, accessible, and science-backed health solutions, Euda is positioned to lead the transformation of regional healthcare from reactive medical treatment to proactive, longevity-focused care.

News Releases

55

EUDA Partners with Authorized Distributor of Guangdong Cell Biotech to Offer Stem Cell Therapies to Customers in Singapore and Malaysia

SINGAPORE, April 24, 2025 (GLOBE NEWSWIRE) -- EUDA Health Holdings Limited (“EUDA” or the “Company”) (NASDAQ: EUDA), a Singapore-based property management services provider and a leading non-invasive healthcare provider in Singapore and Malaysia, today announced an update to the potential strategic partnership, previously announced in December 2024, with Guangdong Cell Biotech Co. Ltd. (“Guangdong Cell Biotech”). Guangdong Cell Biotech is a prominent player in stem cell therapies and regenerative medicine in China. It develops autologous cell treatments and tailored medicines for various disorders.

44

EUDA Holdings and Guangdong Cell Biotech Explore Potential Strategic Partnership to Advance Biotechnology Innovation

SINGAPORE, Dec. 16, 2024 (GLOBE NEWSWIRE) -- EUDA Health Holdings Limited (“EUDA” or the “Company”) (NASDAQ: EUDA), a Singapore-based health technology company that operates a first-of-its-kind Southeast Asian digital healthcare ecosystem, today announced that it has entered into preliminary discussions with Guangdong Cell Biotech Co. Ltd. (“Guangdong Cell Biotech”), a prominent player in stem cell therapies and regenerative medicine, to form a joint venture.

health,care,medical,stock,market,industry,sector,wall,street,buildings

EUDA Health Holdings Limited Completes Acquisition of CK Health Plus Sdn Bhd, Expanding into Direct Selling Holistic Wellness Products in Southeast Asia

Singapore, May 08, 2024 (GLOBE NEWSWIRE) -- EUDA Health Holdings Limited (“EUDA” or the “Company”) (NASDAQ: EUDA), a Singapore-based health technology company that operates a first-of-its-kind Southeast Asian digital healthcare ecosystem, proudly announces the successful completion of its acquisition of CK Health Plus Sdn Bhd (“CK Health”) today. This strategic move marks an expansion of EUDA's presence in Malaysia and underscores its commitment to revolutionizing the healthcare landscape in the region.

SEC Filings

Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act
Form Type: 6-K
Form of prospectus disclosing information, facts, events covered in both forms 424B2, 424B3
Form Type: 424B5
Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act
Form Type: 6-K
nasdaq

NASDAQ CM: EUDA

$3.18

+0.06 (1.92%)

Minimum 15 minutes delayed. Source: LSEG

Scroll to Top